STACY NORMAN: Open Payments
NPI 1417146655 · LAGUNA HILLS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,828 in 78 payments from 17 companies in 2025. Trend: 2023 $1,813 · 2024 $2,332 · 2025 $2,828
Food & beverage: $2,829
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 10 | $600 |
| Arcutis Biotherapeutics, Inc. | 7 | $318 |
| Janssen Biotech, Inc. | 6 | $239 |
| Journey Medical Corporation | 3 | $234 |
| UCB, Inc. | 3 | $191 |
| GENZYME CORPORATION | 5 | $191 |
| ABBVIE INC. | 20 | $189 |
| PFIZER INC. | 4 | $161 |
| Novartis Pharmaceuticals Corporation | 5 | $139 |
| E.R. Squibb & Sons, L.L.C. | 1 | $137 |
Products named: NEMLUVIO, TREMFYA, Zoryve, DUPIXENT, Bimzelx, CIBINQO, Sotyktu, SKYRIZI.
Industry payments across CA — which companies pay providers there.
